Search Results
118 items found for "bryan roth"
- Ep 24 with Dr. Masha Niv
Her work focuses on both sweet and bitter taste receptor GPCRs and her lab established the BitterDB .
- Ep 55 with Mark Schmeizl
He has successfully built numerous global life science, leadership teams, & works closely with both clients
- Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach
The expression prevalence of both receptors tends to decline with tumor progression. However, an unexpected upregulation of both SST2 and SST3 reemerged in metastases suggesting conserved
- Ep 55 with Mark Schmeizl
He has successfully built numerous global life science, leadership teams, & works closely with both clients
- Ep 24 with Dr. Masha Niv
Her work focuses on both sweet and bitter taste receptor GPCRs and her lab established the BitterDB .
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
Currently, the exact function of the C5aR2 is actively debated in the context of C5aR1, even though both to be context-dependent compared to the C5aR1, which has received enormous attention for its role in both
- Deletion of macrophage Gpr101 disrupts their phenotype and function dysregulating host immune responses in sterile and infectious inflammation
Together these findings identify Gpr101 as a novel regulator of both macrophage phenotype and function , modulating key biological activities in both limiting the propagation of inflammation and expediting
- Ep 83 with Dr. Jean-Philippe Pin
such as the activation of cell surface receptors by intracellular proteins; the regulation of GPCRs by both
- Ep 21 with Dr. Maria Waldhoer
Even though Maria stumbled upon the GPCR field, her 20 years in both academia and in the industry working
- TIPE proteins control directed migration of human T cells by directing GPCR and lipid second messenger signaling
Using both gene knockdown and biochemical methods, we demonstrated here that two human TIPE family members T Cells deficient in both of these proteins completely lost their directionality.
- Dr. GPCR Summit 2021 | Dr. GPCR Ecosystem
Make sure you have a profile picture set for both Zoom and Microsoft Teams! Cons: It may take more time to record an excellent presentation, but nothing is impossible!
- Ep 20 with Dr. Jennifer Pluznick
as a postdoctoral fellow in the laboratory of Michael Caplan at Yale University, where she studied both
- Ep 11 with Genemode
Although both went to the same college, Jacob and Jin choose different career paths.
- Ep 138 with Dr. Daniel Isom
went on to earn a Ph.D. in Molecular Biophysics from Johns Hopkins University, followed by postdocs at both
- Ep 20 with Dr. Jennifer Pluznick
as a postdoctoral fellow in the laboratory of Michael Caplan at Yale University, where she studied both
- Ep 138 with Dr. Daniel Isom
went on to earn a Ph.D. in Molecular Biophysics from Johns Hopkins University, followed by postdocs at both
- Ep 79 with Dr. Graeme Milligan
Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for
- Ep 79 with Dr. Graeme Milligan
Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for
- Ep 85 with Nicholas Holliday
Excellerate is involved in several pre-clinical drug discovery projects for both GPCR and non-GPCR targets
- Ep 59 with Dr. Nicola J. Smith
Smith’s team has made advances in the understanding of how an orphan GPCR exerts its effects both in
- Ep 59 with Dr. Nicola J. Smith
Smith’s team has made advances in the understanding of how an orphan GPCR exerts its effects both in
- Ep 141 with Dr Tobi Langenhan
through which I gained an M.Sc. from Somerville College and a D.Phil. from Magdalen College Oxford, both
- Ep 31 with Dr. Kevin Pfleger
I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the
- 22-10 Dr GPCR Newsletter
Brian Schoichet . As a premium Dr. Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C isozymes
- Ep 32 with Dr. Chris Tate
Chris also worked on the E. coli multidrug transporter EmrE and obtained both 2D and 3D crystals as well
- Ep 48 with Dr Nyla Naim Dr Michael Lemieux Dr Jason Nasse from Addgene
Neuroscience from Ohio State University focusing on synaptic plasticity and adrenergic receptor modulation of both
- Ep 48 with Dr Nyla Naim Dr Michael Lemieux Dr Jason Nasse from Addgene
Neuroscience from Ohio State University focusing on synaptic plasticity and adrenergic receptor modulation of both
- Ep 32 with Dr. Chris Tate
Chris also worked on the E. coli multidrug transporter EmrE and obtained both 2D and 3D crystals as well